Genetic risk factors for type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Type 1 diabetes (T1D) diagnosis follows a prodromal phase of beta-cell autoimmunity.
• Autoantibodies against insulin, glutamic acid decarboxylase (GAD), islet antigen-2 (IA-2), and ZnT8 transporter are key biomarkers.
• Genetic predisposition, particularly HLA-DR3-DQ2 and HLA-DR4-DQ8 haplotypes, is a primary risk factor.

Purpose of the Study:

• To elucidate the role of autoantibodies in Type 1 diabetes pathogenesis.
• To understand the relationship between autoantibody profiles and disease progression.
• To explore Type 1 diabetes as a model for other organ-specific autoimmune diseases.

Main Methods:

• Analysis of autoantibody presence and types in individuals with Type 1 diabetes.
• Correlation of autoantibody profiles with genetic risk factors (HLA haplotypes).
• Staging of disease pathogenesis based on autoimmunity, glycemic control, and symptoms.

Main Results:

• The presence of multiple beta-cell autoantibodies correlates with a higher risk of rapid Type 1 diabetes progression.
• Autoantibodies serve as reproducible biomarkers of the underlying autoimmune process.
• Environmental triggers are generally required for disease onset in genetically susceptible individuals.

Conclusions:

• The number of autoantibody types is a significant predictor of Type 1 diabetes progression.
• Type 1 diabetes pathogenesis can be divided into distinct stages, with varying genetic associations.
• T1D serves as a valuable model for studying other autoimmune disorders with prolonged preclinical phases.